Free Trial

Tourmaline Bio (TRML) Earnings Date, Estimates & Call Transcripts

Tourmaline Bio logo
$20.65 +0.31 (+1.52%)
(As of 12/20/2024 05:31 PM ET)

Tourmaline Bio Latest Earnings Summary

Actual EPS
(Nov. 7)
-$0.78 Beat By $0.06
Consensus EPS
(Nov. 7)
-$0.84

Tourmaline Bio released Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.78, which topped the consensus estimate of -$0.84 by $0.06. With a trailing EPS of -$2.82, Tourmaline Bio's earnings are expected to decrease next year, from ($2.99) to ($3.56) per share.

Get Tourmaline Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tourmaline Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TRML Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRML Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Tourmaline Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.70-$0.55-$0.63
Q2 20242-$0.70-$0.57-$0.64
Q3 20242-$0.75-$0.62-$0.69
Q4 20242-$0.82-$0.66-$0.74
FY 20248-$2.97-$2.40-$2.69
Q1 20251-$0.85-$0.85-$0.85
Q2 20251-$0.86-$0.86-$0.86
Q3 20251-$0.86-$0.86-$0.86
Q4 20251-$0.86-$0.86-$0.86
FY 20254($3.43)($3.43)($3.43)

Tourmaline Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024--$0.84-$0.78+$0.06-$0.78--
8/8/2024--$0.72-$0.68+$0.04-$0.68--
5/13/2024Q1 2024-$0.68-$0.55+$0.13-$0.55--
3/19/2024Q4 2023-$0.75-$0.81 -$0.06-$0.81--
11/14/2023Q3 2023-$0.94-$1.64 -$0.70-$1.64--
8/14/2023Q2 2023--$2.00 -$2.00-$0.50--
5/15/2023Q1 2023--$5.40 -$5.40-$5.40--
3/31/2023Q4 2022--$4.40 -$4.40-$4.40--

Tourmaline Bio Earnings - Frequently Asked Questions

Tourmaline Bio (NASDAQ:TRML) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on TRML's earnings history.

In the previous quarter, Tourmaline Bio (NASDAQ:TRML) reported ($0.78) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.84) by $0.06. Learn more on analysts' earnings estimate vs. TRML's actual earnings.

Tourmaline Bio (NASDAQ:TRML) has a recorded net income of -$42.12 million. TRML has generated -$2.82 earnings per share over the last four quarters.

Tourmaline Bio's earnings are expected to decrease from ($2.99) per share to ($3.56) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:TRML) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners